Rituximab maintenance for 2-years in patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy

Autor: Salles, GA, Seymour, JF, Feugier, P, Offner, F, Lopez-Guillermo, A, Bouabdallah, R, Pedersen, LM, Brice, P, Belada, D, Xerri, L

Publikováno v: Salles, GA, Seymour, JF, Feugier, P, Offner, F, Lopez-Guillermo, A, Bouabdallah, R, Pedersen, LM, Brice, P, Belada, D & Xerri, L 2010, ' Rituximab maintenance for 2-years in patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy ', Journal of Clinical Oncology, vol. 28, no. 15s, pp. abstr. 8004 . < http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=74&abstractID=44082 >

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::0ea4ef3e902f3f7e88ce07abe1d64d33
http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=74&abstractID=44082

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.

Autor: Torka P; Memorial Sloan Kettering Cancer Center, New York, NY., Feldman T; John Theurer Cancer Center, Hackensack, NJ., Savage KJ; BC Cancer Agency, Vancouver, British Columbia, Canada., Ganesan N; Memorial Sloan Kettering Cancer Center, New York, NY., Drill E; Memorial Sloan Kettering Cancer Center, New York, NY., Hancock H; Memorial Sloan Kettering Cancer Center, New York, NY., Davey T; Memorial Sloan Kettering Cancer Center, New York, NY., Perez L; Memorial Sloan Kettering Cancer Center, New York, NY., Capadona C; Memorial Sloan Kettering Cancer Center, New York, NY., Subzwari S; Memorial Sloan Kettering Cancer Center, New York, NY., Galasso N; Memorial Sloan Kettering Cancer Center, New York, NY., Yang J; BC Cancer Agency, Vancouver, British Columbia, Canada., Post M; BC Cancer Agency, Vancouver, British Columbia, Canada., Boardman A; Memorial Sloan Kettering Cancer Center, New York, NY., Caron P; Memorial Sloan Kettering Cancer Center, New York, NY., David K; Memorial Sloan Kettering Cancer Center, New York, NY., Epstein-Peterson Z; Memorial Sloan Kettering Cancer Center, New York, NY., Falchi L; Memorial Sloan Kettering Cancer Center, New York, NY., Ghione P; Memorial Sloan Kettering Cancer Center, New York, NY., Hamlin P; Memorial Sloan Kettering Cancer Center, New York, NY., Horwitz SM; Memorial Sloan Kettering Cancer Center, New York, NY., Intlekofer AM; Memorial Sloan Kettering Cancer Center, New York, NY., Johnson W; Memorial Sloan Kettering Cancer Center, New York, NY., Kumar A; Memorial Sloan Kettering Cancer Center, New York, NY., Lue J; Memorial Sloan Kettering Cancer Center, New York, NY., Noy A; Memorial Sloan Kettering Cancer Center, New York, NY., Owens C; Memorial Sloan Kettering Cancer Center, New York, NY., Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY., Salles GA; Memorial Sloan Kettering Cancer Center, New York, NY., Steiner R; Memorial Sloan Kettering Cancer Center, New York, NY., Stuver R; Memorial Sloan Kettering Cancer Center, New York, NY., Vardhana S; Memorial Sloan Kettering Cancer Center, New York, NY., Yahalom J; Memorial Sloan Kettering Cancer Center, New York, NY., Dogan A; Memorial Sloan Kettering Cancer Center, New York, NY., Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, NY., Schöder H; Memorial Sloan Kettering Cancer Center, New York, NY., Moskowitz AJ; Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec 11, pp. JCO2401278. Date of Electronic Publication: 2024 Dec 11.

Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation.

Autor: Kumar A; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Soumerai JD; Massachusetts General Hospital Cancer Center: Hematology Oncology, Boston, Massachusetts, United States., Abramson JS; Mass General Cancer Center, Boston, Massachusetts, United States., Barnes JA; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States., Caron PC; Memorial Sloan Kettering Cancer Center, West Harrison, New York, United States., Chhabra S; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Chabowska M; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Dogan A; Memorial Sloan-Kettering Cancer Center, New York, New York, United States., Falchi L; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Grieve C; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Haydu JE; Mass General Cancer Center, Boston, Massachusetts, United States., Johnson PC; Massachusetts General Hospital / Harvard Medical School, Boston, Massachusetts, Massachusetts, United States., Joseph A; Memorial Sloan-Kettering Cancer Center, New York, New York, United States., Kelly H; Massachusetts General Hospital Cancer Center: Hematology Oncology, Boston, Massachusetts, United States., Labarre A; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Lue JK; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Martignetti R; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States., Mi J; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Moskowitz AJ; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Owens CN; Memorial Sloan Kettering Cancer Center, Middletown, New Jersey, United States., Plummer S; Massachusetts General Hospital Cancer Center: Hematology Oncology, Boston, Massachusetts, United States., Puccio M; Massachusetts General Hospital Cancer Center: Hematology Oncology, Boston, Massachusetts, United States., Salles GA; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Seshan VE; MSKCC, New York, New York, United States., Simkins E; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States., Slupe N; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Zhang H; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, New York, United States.

Publikováno v: Blood [Blood] 2024 Oct 22. Date of Electronic Publication: 2024 Oct 22.

Intratumoral T-cell composition predicts epcoritamab-based treatment efficacy in B-cell non-Hodgkin lymphomas.

Autor: Falchi L; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY, USA., Rahman J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Epidemiology and Biostatistics, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY., Melendez L; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY., Douglas M; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY., Amador WR; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY., Hamlin P; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY, USA., Kumar A; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY, USA., Hoehn D; Genmab, Princeton, NJ., Lin YH; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY., Gao Q; Hematopathology service, Department of Pathology and Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Roshal M; Hematopathology service, Department of Pathology and Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Ewalt MD; Hematopathology service, Department of Pathology and Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.; Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Dogan A; Hematopathology service, Department of Pathology and Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Greenbaum B; Department of Epidemiology and Biostatistics, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY., Salles GA; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY, USA., Vardhana SA; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Jul 05. Date of Electronic Publication: 2024 Jul 05.

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma.

Autor: Lin RJ; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Kim SJ; Geriatrics Service, Memorial Sloan Kettering Cancer Center, New York, NY., Brown S; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Elko TA; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY., Ruiz JD; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY., Hanley DM; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY., Lia Palomba M; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Perales MA; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Shah GL; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Dahi PB; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Scordo M; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Sauter CS; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Batlevi CL; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Tomas AA; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY., Shouval R; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Lee N; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY., Pavkovic EA; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY., Engstler DE; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY., Park JH; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Salles GA; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Devlin SM; Weill Cornell Medical College, New York, NY.; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Korc-Grodzicki B; Weill Cornell Medical College, New York, NY.; Geriatrics Service, Memorial Sloan Kettering Cancer Center, New York, NY., Hamlin PA; Weill Cornell Medical College, New York, NY.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Giralt SA; Adult Blood and Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.

Publikováno v: Blood advances [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3501-3505.